| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2843450 | 41 | F | CA | 06/01/2025 |
COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
|
Adnexa uteri pain, Asthenia, Dizziness, Fatigue, Haematocrit decreased; Haemoglo...
Adnexa uteri pain, Asthenia, Dizziness, Fatigue, Haematocrit decreased; Haemoglobin decreased, Haemorrhagic ovarian cyst, Heavy menstrual bleeding, Lethargy, Loss of personal independence in daily activities; Mean cell haemoglobin concentration decreased, Mean cell haemoglobin decreased, Menstrual disorder, Renal pain
More
|
The patient's menstrual cycle began two days after the vaccine and has not stopped. So from Apr...
The patient's menstrual cycle began two days after the vaccine and has not stopped. So from April 15 to at least June 1st she has been menstrating and has had severe symptoms such as pain in the ovaries and kidneys. She was given birth control progesterone for one month which did not stop the bleeding entirely. The patient reported mostly heavy days with a few days of light bleeding. In May, the patient had an ultrasound done which showed several hemorrhagic cysts had formed on both ovaries. The patient asked to be removed from the birth control as she felt it was making her even sicker, with more kidney pain, nausea, and moodiness. The patient had significant difficulty doing her normal work, and quit her full time job because she could not function mentally because of the pain of her menstration. She claims her mind is constantly in anguish from the bleeding and her ovaries feel as if they are experiencing twisting and burning. She has tried to get out of the house and walk but complains she feels very tired, lightheaded, lethargic, with very limited energy. The patient kept track of her periods for years which were always regular 4-5 days every 23-28 days. This is the first/only instance of trouble with her menstraul cycle being abnormal. She is in pain and wants medical advice on how to stop the bleeding.
More
|
||||||
| 2843451 | 51 | M | MI | 06/01/2025 |
COVID19 |
PFIZER\BIONTECH |
EWD0176 |
Attention deficit hyperactivity disorder, Condition aggravated, Depression, Diab...
Attention deficit hyperactivity disorder, Condition aggravated, Depression, Diabetic neuropathy, Type 2 diabetes mellitus
More
|
Diabetes about 1 year later and increase in depression.
Diabetes about 1 year later and increase in depression.
|
โ | |||||
| 2843452 | 77 | M | NC | 06/01/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
PJ35 |
Inappropriate schedule of product administration, Respiratory rate decreased
Inappropriate schedule of product administration, Respiratory rate decreased
|
Patient received his 2nd shingles vaccine yesterday. It was not within the 2-6 month range. The pre...
Patient received his 2nd shingles vaccine yesterday. It was not within the 2-6 month range. The previous was March of 2024. The patient does have COPD and when he got home , he felt as if his breathing was slowed down. He did go to the ER and was given a antibiotic and naproxen.
More
|
||||||
| 2843453 | 42 | M | PA | 06/01/2025 |
HPV9 |
MERCK & CO. INC. |
|
Brain fog, Dizziness, Fatigue
Brain fog, Dizziness, Fatigue
|
- Day 0?3 post-vaccination: Onset of symptoms including dizziness, lightheadedness, brain fog, and ...
- Day 0?3 post-vaccination: Onset of symptoms including dizziness, lightheadedness, brain fog, and extreme fatigue. These symptoms were new and sudden, distinct from prior autoimmune flares. - Day 4?14: Symptoms gradually improved, returning close to baseline. - Day 15?30: Symptoms returned abruptly, now including neck stiffness, increased cognitive dysfunction, and worsened lightheadedness, especially after meals or prolonged standing. - Present status: Symptoms are persistent and interfere with daily functioning. Strong suspicion of autonomic nervous system involvement (e.g., POTS, dysautonomia) and/or small fiber neuropathy flare, likely autoimmune in nature.
More
|
||||||
| 2843454 | 76 | M | NY | 06/01/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
MG5S9 |
Injection site rash, Rash, Rash erythematous, Rash pruritic
Injection site rash, Rash, Rash erythematous, Rash pruritic
|
Patient had rash down left arm from injection site to wrist, also had rash on right side of neck and...
Patient had rash down left arm from injection site to wrist, also had rash on right side of neck and chest. Red itchy rash that looked like hives.
More
|
||||||
| 2843455 | 78 | M | GA | 06/01/2025 |
HEPAB |
GLAXOSMITHKLINE BIOLOGICALS |
M4B34 |
Extra dose administered
Extra dose administered
|
Patient came to the pharmacy asked if he could get the Twinrix, we gave him the vaccine on 11/7/24 a...
Patient came to the pharmacy asked if he could get the Twinrix, we gave him the vaccine on 11/7/24 and he came back on 12/14/25 after receiving the text notification that he is due for the 2nd dose, he came back again after 5 months after getting the notification for the 3rd dose but after checking the database, it shows that he already received 2 incomplete doses from pharmacy in 2023. He wanted to get the 3rd dose from another pharmacy but we informed him that he already received total of 4 doses since 2023.
More
|
||||||
| 2843456 | 4 | M | MI | 06/01/2025 |
MMR |
MERCK & CO. INC. |
X026328 |
Anaphylactic reaction, Cough, Rhinorrhoea, Throat clearing
Anaphylactic reaction, Cough, Rhinorrhoea, Throat clearing
|
Anaphylaxis - coughing, throat clearing, runny nose
Anaphylaxis - coughing, throat clearing, runny nose
|
||||||
| 2843457 | 75 | F | SC | 06/01/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
E754F |
Injection site pruritus, Injection site swelling, Injection site warmth
Injection site pruritus, Injection site swelling, Injection site warmth
|
Localized reaction aprox. 4" around injection site. Swollen, itchy, warm.
Localized reaction aprox. 4" around injection site. Swollen, itchy, warm.
|
||||||
| 2843458 | 53 | F | CO | 06/01/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
75GZ7 |
Colonoscopy, Diarrhoea
Colonoscopy, Diarrhoea
|
Patient experiencing Diarrhea for 8 weeks and currently ongoing. Patient is treated with medication ...
Patient experiencing Diarrhea for 8 weeks and currently ongoing. Patient is treated with medication to manage adverse event.
More
|
||||||
| 2843459 | 4 | F | NE | 06/01/2025 |
DTAPIPV |
GLAXOSMITHKLINE BIOLOGICALS |
4L454 |
Injection site cellulitis, Injection site hypersensitivity
Injection site cellulitis, Injection site hypersensitivity
|
cellulitis/hypersensitive site reaction
cellulitis/hypersensitive site reaction
|
||||||
| 2843460 | 37 | F | MO | 06/01/2025 |
HEPA |
GLAXOSMITHKLINE BIOLOGICALS |
ey57a |
Loss of consciousness, Vomiting
Loss of consciousness, Vomiting
|
Patient passed out and also vomited
Patient passed out and also vomited
|
||||||
| 2843461 | 78 | M | NJ | 06/01/2025 |
TDAP VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
LK494 EK225 |
Joint swelling, Rash; Joint swelling, Rash
Joint swelling, Rash; Joint swelling, Rash
|
PATIENT EXPERIANCING RASH, ANKLE SWELLING
PATIENT EXPERIANCING RASH, ANKLE SWELLING
|
||||||
| 2843462 | 65 | M | CO | 06/01/2025 |
COVID19 FLU3 MMR PNC21 |
PFIZER\BIONTECH SANOFI PASTEUR MERCK & CO. INC. MERCK & CO. INC. |
LM7786 U8527BA X018902 Y013009 |
Mobility decreased, Pain in extremity; Mobility decreased, Pain in extremity; Mo...
Mobility decreased, Pain in extremity; Mobility decreased, Pain in extremity; Mobility decreased, Pain in extremity; Mobility decreased, Pain in extremity
More
|
Patient reported a sore arm off and on since receiving vaccines which is typically worse at night an...
Patient reported a sore arm off and on since receiving vaccines which is typically worse at night and sometimes makes it hard to pick up objects. Patient states he heard/read that MRNA vaccines just stay in the muscle. No treatment mentioned and has be occurring since 3/18/2025 when vaccines were administered. No follow up has occurred with PCP per patient.
More
|
||||||
| 2843463 | 0.25 | F | 06/01/2025 |
DTAPHEPBIP HIBV PNC20 RV1 |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
TC47K 97F4B HM8949 |
Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness; Crying, Hem...
Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness; Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness; Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness; Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness
More
|
Unconsolable crying started within twenty-four hours and continued for days without ceasing; fussine...
Unconsolable crying started within twenty-four hours and continued for days without ceasing; fussiness continued for weeks. Unilateral weakness turning to stiffness down one side of body as if paralysis (arm and leg on same side), change in crying voice. Corresponded with pediatrician office.
More
|
|||||||
| 2843501 | 61 | F | CA | 06/01/2025 |
PNC21 PNC21 |
MERCK & CO. INC. MERCK & CO. INC. |
Y011819 Y011819 |
Asthenia, Chills, Hand-foot-and-mouth disease, Malaise, Migraine; Pyrexia, Tachy...
Asthenia, Chills, Hand-foot-and-mouth disease, Malaise, Migraine; Pyrexia, Tachycardia, Vomiting, White blood cell count increased
More
|
patient stated that she felt sick after the vaccine with chills, fever, vomit, migraine, weakness, t...
patient stated that she felt sick after the vaccine with chills, fever, vomit, migraine, weakness, tachycardia, and elevated WBC treated with Vancomycin. was also given Benadryl in the hospital. She picked up Norco 5mg at pharmacy on 5/1/2025 prescriptions stated for migraine. Then was seen by her primary care doctor on 5/1/2025 for prescriptions for Ibuprofen, valtrex , triamcinolone, for hand foot mouth disease that she says that she got at the hospital on 4/29/25.
More
|
||||||
| 2843502 | 48 | M | TX | 06/01/2025 |
HEP |
DYNAVAX TECHNOLOGIES CORPORATION |
944942 |
Extra dose administered
Extra dose administered
|
NONE
NONE
|
||||||
| 2843503 | 1.25 | F | GA | 06/01/2025 |
DTPPVHBHPB DTPPVHBHPB DTPPVHBHPB PNC20 PNC20 PNC20 |
MSP VACCINE COMPANY MSP VACCINE COMPANY MSP VACCINE COMPANY PFIZER\WYETH PFIZER\WYETH PFIZER\WYETH |
|
Amylase normal, Blood calcium, Blood culture, Blood gases normal, C-reactive pro...
Amylase normal, Blood calcium, Blood culture, Blood gases normal, C-reactive protein; Differential white blood cell count, Febrile convulsion, Full blood count, Irritability, Metabolic function test; Musculoskeletal stiffness, Procalcitonin; Amylase normal, Blood calcium, Blood culture, Blood gases normal, C-reactive protein; Differential white blood cell count, Febrile convulsion, Full blood count, Irritability, Metabolic function test; Musculoskeletal stiffness, Procalcitonin
More
|
Febrile seizures Evaluated at ER for febrile seizure, ruled by attending physician to be vaccine-in...
Febrile seizures Evaluated at ER for febrile seizure, ruled by attending physician to be vaccine-induced. All tests including blood gases and urine were normal; nasal swab not performed. Highest recorded temperature was 101๏ฟฝF, rectal temperature prior to visit was 97.3๏ฟฝF. Mother reports full-body seizure 05/21/2025 at 1900 hours, lasting 1-2 seconds, occurring every minute for 10 minutes for a total of 13 seizures. Patient had bowel movement and urination with each seizure, full diaper after 10 minutes. Transported via ambulance to hospital, where another seizure occurred in the emergency room. Condition improved the following day: more consolable, less irritable, eating and drinking well, normal bowel movements and urination, walking independently today but needed walker assistance day after ER visit, playful, taking two naps instead of one. Mother reports possible minor seizure 5/22/2025, woke up at 0230 hours with heart rate 89 and oxygen saturation 98-99. Patient woke up fine, fell back asleep, back stiffened and arched for a minute, then relaxed. Total 15 seizures between 05/21/2025 and 05/22/2025.
More
|
||||||
| 2843504 | 0.33 | F | 06/01/2025 |
DTAPHEPBIP HIBV PNC20 RV1 |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
5YB7L TC3N5 LA6406 5N2AN |
Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness; Crying, Hem...
Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness; Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness; Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness; Crying, Hemiparesis, Infant irritability, Musculoskeletal stiffness
More
|
Extreme, unconsolable crying for days; fussiness lasted weeks. One sided weakness that progressed i...
Extreme, unconsolable crying for days; fussiness lasted weeks. One sided weakness that progressed into stiff, board-like paralysis on one full side of body. This happened after the two month appointment and was discussed with provider. Provider wished to proceed citing it would confuse office staff to split up the vaccines-the effects were reproduced with the recurrent exposure and lasted longer than the previous encounter, specifically the unilateral, board-like stiffness. Corresponded effects to provider office.
More
|
|||||||
| 2843417 | 1 | M | OH | 05/31/2025 |
MMR |
MERCK & CO. INC. |
S007814 |
Expired product administered, No adverse event
Expired product administered, No adverse event
|
No adverse effects reported.; Product was expired 3/14/2021, was administered on 4/1/2021.; This sp...
No adverse effects reported.; Product was expired 3/14/2021, was administered on 4/1/2021.; This spontaneous report was received from a Nurse and refers to an 1-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 01-APR-2021, the patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Injection, lot #S007814, expiration date reported as 14-MAR-2021 (dose, strength, route of administration, anatomical location of vaccine were not reported) and diluted with sterile diluent (MERCK STERILE DILUENT) (expiration date, and lot # were not reported) for prophylaxis. The patient did not experience adverse effects.
More
|
||||||
| 2843418 | M | CT | 05/31/2025 |
MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS |
AMABO56A |
Product preparation error
Product preparation error
|
reconstituted with sterile water instead of the MenCYW-135; Menveo - Reconstitution with sterile wat...
reconstituted with sterile water instead of the MenCYW-135; Menveo - Reconstitution with sterile water; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 15-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMABO56A, expiry date 31-AUG-2025) for prophylaxis. On 28-MAY-2025, the patient received Menveo. On 28-MAY-2025, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: reconstituted with sterile water instead of the MenCYW-135) and inappropriate dose of vaccine administered (Verbatim: Menveo - Reconstitution with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 28-MAY-2025 A nurse reported that a patient was given a dose of Menveo (2 vial) that was reconstituted with sterile water instead of the MenCYW-135 liquid component which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The nurse asked for the recommended interval to repeat the dose. Consented to follow up.
More
|
|||||||
| 2843431 | 58 | F | 05/31/2025 |
PNC20 |
PFIZER\WYETH |
lj5280 |
Chills, Influenza like illness, Malaise, Pyrexia
Chills, Influenza like illness, Malaise, Pyrexia
|
Patient called and states she is having a reaction to the vaccine she received on Saturday. She stat...
Patient called and states she is having a reaction to the vaccine she received on Saturday. She states she started having flu-like symptoms (fever, chills, general malaise) on Sunday, followed by an injection site reaction starting Monday. She called concerning her arm. She is experiencing swelling, pain, redness, warmth, itching and it?s ?hard?. The affected area starts at the shoulder and extends about 4 inches. I advised her to ice on and off for 20minutes, take Tylenol, and Benadryl before bed, if no relief in 24hrs or symptoms worsen to have it examined by provider. 48 hours late, patient reports arm is still symptomatic, but is improving.
More
|
|||||||
| 2843432 | 77 | M | CA | 05/31/2025 |
COVID19 |
MODERNA |
3046732 |
Arthralgia
Arthralgia
|
joint pain left wrist knee and ankle
joint pain left wrist knee and ankle
|
||||||
| 2843433 | 79 | F | FL | 05/31/2025 |
RSV |
PFIZER\WYETH |
HY1812 |
Injection site erythema, Injection site swelling
Injection site erythema, Injection site swelling
|
Swelling and erythema at injection site 2 days after vaccination.
Swelling and erythema at injection site 2 days after vaccination.
|
||||||
| 2843434 | 50 | F | PA | 05/31/2025 |
PNC21 PNC21 PNC21 |
MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
|
Arthralgia, Asthenia, Back pain, Burning sensation, Dizziness; Ear pain, Headach...
Arthralgia, Asthenia, Back pain, Burning sensation, Dizziness; Ear pain, Headache, Hyperhidrosis, Myalgia, Nausea; Neck pain, Oropharyngeal pain, Pain in extremity, Tunnel vision
More
|
Deep muscle or pain and burning in left arm down tips of fingers. Throat and ears hurt. Dizziness, n...
Deep muscle or pain and burning in left arm down tips of fingers. Throat and ears hurt. Dizziness, nausea, feeling faint, eye sight change to tunnel vision and darkness, sweating, and weakness. Neck and shoulder pain. Weakness and lower back pain with left leg pain, and headache.
More
|
||||||
| 2843435 | 43 | M | WI | 05/31/2025 |
COVID19 COVID19 COVID19 COVID19 |
MODERNA MODERNA MODERNA MODERNA |
018B521A 018B521A 030A21A 030A21A |
Acne, Arthropod bite, Laboratory test, Magnetic resonance imaging head, Staphylo...
Acne, Arthropod bite, Laboratory test, Magnetic resonance imaging head, Staphylococcal infection; Swelling of eyelid; Acne, Arthropod bite, Laboratory test, Magnetic resonance imaging head, Staphylococcal infection; Swelling of eyelid
More
|
Developed MRSA four different times in a row in 2021, first infection developed from a minor bug bit...
Developed MRSA four different times in a row in 2021, first infection developed from a minor bug bite and took over a month to treat, daily visits to the walk-in clinic. This repeated itself with another MRSA infection from a pimple 3 other times. Had to get an MRI to see if the infection had spread to my eyes and they had been swollen shut for 4 days I couldn't see.
More
|
โ | |||||
| 2843436 | 64 | F | FL | 05/31/2025 |
COVID19 COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
Ew0196 Ew0196 Fc3l84 Fc3l84 |
Balance disorder, Deafness, Dizziness, Hearing aid user, Laboratory test; Magnet...
Balance disorder, Deafness, Dizziness, Hearing aid user, Laboratory test; Magnetic resonance imaging, Vertigo; Balance disorder, Deafness, Dizziness, Hearing aid user, Laboratory test; Magnetic resonance imaging, Vertigo
More
|
SEVERE VERTIGO, both times of the required 2 shot required, first 08/24/2021, second required was 9/...
SEVERE VERTIGO, both times of the required 2 shot required, first 08/24/2021, second required was 9/14/2021
More
|
โ | |||||
| 2843437 | 58 | F | VA | 05/31/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
Y7XG3 |
Rash, Rash erythematous, Rash pruritic
Rash, Rash erythematous, Rash pruritic
|
PATIENT COMPLAINED OF A RED VERY ITCHY RASHES ON TORSO - UPPER BACK / THORAX / ARMPITS / BREASTS AN...
PATIENT COMPLAINED OF A RED VERY ITCHY RASHES ON TORSO - UPPER BACK / THORAX / ARMPITS / BREASTS AND MOVING TO NECK A SHORT WHILE AFTER THE VACCINE WAS ADMINISTERED .
More
|
||||||
| 2843438 | 57 | F | OK | 05/31/2025 |
PNC21 |
MERCK & CO. INC. |
y019157 |
Rash
Rash
|
rash and hospitalized
rash and hospitalized
|
||||||
| 2843439 | 51 | F | IN | 05/31/2025 |
COVID19 COVID19 PNC21 PNC21 |
MODERNA MODERNA MERCK & CO. INC. MERCK & CO. INC. |
|
Arthralgia, Chills, Dysgeusia, Fatigue, Headache; Injection site erythema, Injec...
Arthralgia, Chills, Dysgeusia, Fatigue, Headache; Injection site erythema, Injection site pain, Injection site swelling, Myalgia, Pyrexia; Arthralgia, Chills, Dysgeusia, Fatigue, Headache; Injection site erythema, Injection site pain, Injection site swelling, Myalgia, Pyrexia
More
|
Moderate redness/pain/swelling at injection site (4?x4?), headache, joint pain, muscle aches, fever...
Moderate redness/pain/swelling at injection site (4?x4?), headache, joint pain, muscle aches, feverish, chills, fatigue, food tastes strange,
More
|
||||||
| 2843441 | 71 | F | PA | 05/31/2025 |
PNC21 PNC21 PNC21 PNC21 RSV RSV RSV RSV |
MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
Z004301 Z004301 Z004301 Z004301 4B22T 4B22T 4B22T 4B22T |
Blood culture, Blood lactic acid, Blood test, Cardiac monitoring, Chest X-ray; C...
Blood culture, Blood lactic acid, Blood test, Cardiac monitoring, Chest X-ray; Computerised tomogram abdomen, Culture urine, Electrocardiogram, Full blood count, Gait disturbance; Influenza virus test, Metabolic function test, Pollakiuria, Pyrexia, Respiratory syncytial virus test; SARS-CoV-2 test, Scan with contrast, Troponin, Urine analysis; Blood culture, Blood lactic acid, Blood test, Cardiac monitoring, Chest X-ray; Computerised tomogram abdomen, Culture urine, Electrocardiogram, Full blood count, Gait disturbance; Influenza virus test, Metabolic function test, Pollakiuria, Pyrexia, Respiratory syncytial virus test; SARS-CoV-2 test, Scan with contrast, Troponin, Urine analysis
More
|
Developed high fever of 103 and could barely walk. Also urinating more than normal. Had to call 911...
Developed high fever of 103 and could barely walk. Also urinating more than normal. Had to call 911 times take me to ER
More
|
||||||
| 2843442 | 73 | F | PA | 05/31/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
255T2 |
Dysarthria, Fatigue, Gait disturbance
Dysarthria, Fatigue, Gait disturbance
|
patient had fatigue, unsteady gait, slurred speech
patient had fatigue, unsteady gait, slurred speech
|
||||||
| 2843443 | 1.25 | F | OR | 05/31/2025 |
HEPA PNC20 VARCEL |
GLAXOSMITHKLINE BIOLOGICALS PFIZER\WYETH MERCK & CO. INC. |
LDN273 LN4928 Y005922 |
Pyrexia, Rash erythematous; Pyrexia, Rash erythematous; Pyrexia, Rash erythemato...
Pyrexia, Rash erythematous; Pyrexia, Rash erythematous; Pyrexia, Rash erythematous
More
|
patient attend 15month WCC at Primary Care Office on 5/29/25. Parents reported seeing the beginnings...
patient attend 15month WCC at Primary Care Office on 5/29/25. Parents reported seeing the beginnings of a red pinpointed slightly raised rash on stomach that day while in the exam room PRIOR to receiving 3 of the scheduled vaccines she was due for, but it was minor. what was clear and what prompted a call to the same PCP office on 5/31/25 by both parents, is that the rash started spreading by late 5/29 and clearly morning of 5/30. rash also associated with low grade fever, no higher than 100.4 , but mostly 99. Patient is in no apparent distress, change in behaviors or routines, appetite, rash has spread in 24-48 hrs of the visit , if not that night to full stomach, back , bilateral arms and legs, tops of feet's and hands , some on fingers. some scattered around chin area and jaw. slightly raised, not fluid filled yet. does not appear to itch or be painful . fever controlled by Motrin. rash is not deep purple - red pink. not blotchy . various stages of size. has 1 spot on bottom of foot.
More
|
||||||
| 2843444 | 34 | F | NJ | 05/31/2025 |
HPV9 |
MERCK & CO. INC. |
z005055 |
Dizziness, Lethargy, Pallor, Posture abnormal
Dizziness, Lethargy, Pallor, Posture abnormal
|
patient reported feeling faint after exiting vaccine room-she was advised to take a seat to be obser...
patient reported feeling faint after exiting vaccine room-she was advised to take a seat to be observed-patient looked pale and lethargic- head tilted back but was responsive when called and sat up-patient reported she had not eaten-was observed till she looked stronger and was offered a drink-by 15 minutes, patient husband had arrived and she was talking and feeling better and went home.
More
|
||||||
| 2843445 | 27 | M | AZ | 05/31/2025 |
YF YF |
SANOFI PASTEUR SANOFI PASTEUR |
uk125aa uk125aa |
Dizziness, Eye movement disorder, Muscle contractions involuntary, Pallor, Synco...
Dizziness, Eye movement disorder, Muscle contractions involuntary, Pallor, Syncope; Thirst
More
|
After I administered the yellow fever vaccine, patient expressed concerns about feeling sick since h...
After I administered the yellow fever vaccine, patient expressed concerns about feeling sick since he had work that night and the next day. We were discussing about immune support supplements and what to expect if feeling unwell. After a couple minutes of talking, they were about to leave and I was going to direct them to sit outside for a while before heading out, but when patient got up to leave, he felt dizzy and his skin turned pale. Patient's girlfriend and I helped him to sit back down into the chair. Once in the chair, patient took deep slow breaths. I asked his girlfriend if this had ever happen before, but then patient fainted in the chair and his girlfriend held him upright. His body was contracting and eyes rolling to the back of his head. I left the room for help from other pharmacist. Someone helped to call 911, and I tried to call a manager through the phone, but no one picked up, so I went to the front of the warehouse to notify a supervisor to let a manager know 911 was called and to help direct them to the pharmacy. Another person went to the patient to check and make sure they were okay. He mentioned when the patient regained consciousness, he said he was "really thirsty". EMT arrived and they were directed to the vaccine room. We closed the door to give privacy and space. A supervisor came around a couple minutes later to let us know an ambulance was coming through the tire center to gurney the patient out. Once the ambulance arrived, they smoothly came through and helped the patient out.
More
|
||||||
| 2843446 | 35 | M | NY | 05/31/2025 |
COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
FP 7136 FP 7136 FP 7136 |
Asthma, Back pain, Condition aggravated, Dyspnoea exertional, Essential hyperten...
Asthma, Back pain, Condition aggravated, Dyspnoea exertional, Essential hypertension; Insomnia, Persistent depressive disorder, Pollakiuria, Post-traumatic stress disorder, Sciatica; Vitamin D deficiency
More
|
Primary hypertensionPTSD (post-traumatic stress disorderUrinary frequency Short of breath on exertio...
Primary hypertensionPTSD (post-traumatic stress disorderUrinary frequency Short of breath on exertionPersistent depressive disorderBMI 22.0-22.9, adultPrimary insomniaVitamin D deficiencyModerate persistent asthma without complicationChronic bilateral low back pain with left-sided sciaticaPrimary hypertension
More
|
โ | |||||
| 2843447 | 58 | F | CO | 05/31/2025 |
HEPAB PNC21 |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
P2443 Y019157 |
Injection site erythema, Injection site mass, Pyrexia; Injection site erythema, ...
Injection site erythema, Injection site mass, Pyrexia; Injection site erythema, Injection site mass, Pyrexia
More
|
Patient called stating she has had a fever (unknown what temperature as she did not have a thermomet...
Patient called stating she has had a fever (unknown what temperature as she did not have a thermometer), knot at the injection site, and red splotches on her left arm. She stated the redness was not itchy and was in more that one spot on her arm. The redness had not gotten worse over the past 48 hours. Patient has been treating with acetaminophen.
More
|
||||||
| 2843448 | 51 | F | MD | 05/31/2025 |
COVID19 |
PFIZER\BIONTECH |
Ew0198 |
Angina pectoris, Rash macular, Skin discolouration
Angina pectoris, Rash macular, Skin discolouration
|
Heart pain necessitating emergency room visit; rashes and red blotches on and off over the next year...
Heart pain necessitating emergency room visit; rashes and red blotches on and off over the next years. Small Black and blue marks all over arms and legs after vaccination.
More
|
||||||
| 2843254 | F | CA | 05/30/2025 |
HPV9 |
MERCK & CO. INC. |
|
Accident at work, Accidental exposure to product, Injury associated with device,...
Accident at work, Accidental exposure to product, Injury associated with device, Syringe issue
More
|
Accidental exposure; FBE calling on behalf a nurse who reported GARDASIL 9 syringe had broken and in...
Accidental exposure; FBE calling on behalf a nurse who reported GARDASIL 9 syringe had broken and injured another nurse in the practice while administering product on 22APR2025. Filing AE for the nurse injury and filing potential patient AE as it was not confirmed durin; FBE calling on behalf a nurse who reported GARDASIL 9 syringe had broken and injured another nurse in the practice while administering product on 22APR2025. Filing AE for the nurse injury and filing potential patient AE as it was not confirmed durin; This spontaneous report was received from a Nurse and refers to a(n) female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 22-Apr-2025, an unknown patient would be vaccinated with a dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) 0.5 mL (strength, dose, dose number, frequency, vaccination scheme, route, anatomical location, lot # and expiration date were not reported), as prophylaxis (Case # 2282009); however, during the vaccination procedure, the Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) syringe had broken and injured a nurse in the practice while administering product (syringe broken, injury associated with device, accidental exposure to product). The outcome of the event was not reported.
More
|
|||||||
| 2843255 | 5 | MO | 05/30/2025 |
MMRV |
MERCK & CO. INC. |
|
Circumstance or information capable of leading to medication error, Underdose
Circumstance or information capable of leading to medication error, Underdose
|
no adverse event; HCP called and reported a patient who did not receive a full dose of PROQUAD on 13...
no adverse event; HCP called and reported a patient who did not receive a full dose of PROQUAD on 13MAY2025 due to moving their arm during administration. Limited demographics provided. No additional information was known by reporter. No additional AE/PQC.; This spontaneous report was received from a nurse and refers to a 5-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 13-May-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (dose, frequency, route of administration, lot # and expiration date were not reported) as a prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot# and expiration date were not provided). On 13-May-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported). However, the patient did not receive a full dose of due to moving their arm during administration (accidental underdose). No additional information was known by reporter.
More
|
|||||||
| 2843256 | M | FL | 05/30/2025 |
MMRV MMRV MMRV MMRV MMRV MMRV |
MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
Y015355 Y015355 |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
No adverse event; Patient received PROQUAD dose on 3/14/2024, 1/31/2025 and on 3/14/2025; This sp...
No adverse event; Patient received PROQUAD dose on 3/14/2024, 1/31/2025 and on 3/14/2025; This spontaneous report was received from a medical assistant on 13-MAY-2025 and refers to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. Historical vaccines include Measles, mumps, and rubella virus vaccine live (MMRII) and Varicella virus vaccine live (Oka/Merck) (VARIVAX) ad mistered on 01-FEB-2024. On 14-MAR-2024 at another clinic, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot#, expiration date, dose number, anatomical location, route of administration were not reported) and with sterile diluent (MERCK STERILE DILUENT) (lot#, expiration date, dose number, anatomical location, route of administration were not reported) for Prophylaxis. The Medical assistant reported that on 31-JAN-2025 and 14-MAR-2025 , the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y015355, expiration date: 10-MAR-2026), dose 0.5 mL (conflicting information reported as first and second dose respectively by the same reporter) (dose number, anatomical location, route of administration were not reported) and with sterile diluent (MERCK STERILE DILUENT) for prophylaxis (Extra dose administered). No additional adverse event or quality complaint was reported. No additional Adverse events reported.
More
|
|||||||
| 2843257 | 31 | KY | 05/30/2025 |
MMRV MMRV |
MERCK & CO. INC. MERCK & CO. INC. |
Y000225 Y017208 |
Extra dose administered, No adverse event, Product administered to patient of in...
Extra dose administered, No adverse event, Product administered to patient of inappropriate age; Extra dose administered, No adverse event, Product administered to patient of inappropriate age
More
|
no additional AE; a 31 year old patient was administered both PROQUAD and VARIVAX on 4/16/2025.; PRO...
no additional AE; a 31 year old patient was administered both PROQUAD and VARIVAX on 4/16/2025.; PROQUAD was given to a 31-year-old patient; A dose of VARIVAX was given previously on 3/17/2025 and a dose of PROQUAD was given on 3/21/2025 to the same patient.; This spontaneous report was received from a nurse on 27-May-2025 and refers to a 31-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 17-Mar-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), (lot #Y014939, expiration date: 04-Sep-2026) 0.5 ml, administered by Intramuscular route. On 21-Mar-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y000225, expiration date: 03-Jan-2026) 0.5 mL, administered by Intramuscular route (Product administered to patient of inappropriate age, Inappropriate schedule of product administration). On 16-Apr-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), (lot #Y014939, expiration date: 04-Sep-2026) 0.5 ml, administered by Intramuscular route and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y017208, expiration date: 13-Apr-2026) 0.5 mL, administered by Intramuscular route (overdose). The vaccines were reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date unknown). The vaccines were administered as prophylaxis. No additional AE (no adverse event).
More
|
|||||||
| 2843258 | F | 05/30/2025 |
HPV4 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. |
|
Seizure; Seizure
Seizure; Seizure
|
Grandmother of patient reporting that patient began having seizures after having GARDASIL administer...
Grandmother of patient reporting that patient began having seizures after having GARDASIL administered. She is not sure if it was GARDASIL or GARASIL 9. She says it was administered a year or two ago. She does not have any additional information and; This spontaneous report was received from the patient's grandmother and refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. In approximately 2023, reported as "a year or two ago", the patient was vaccinated with the company unidentified Human Papillomavirus (HPV) vaccine (name and lot number not provided), administered by Unknown route (reported as "Injection") for the indication "vaccine". On an unknown date, after having the vaccine, the patient began having seizures. The reporter did not have any additional. At the reporting time, the outcome of seizures was unknown. The causal relationship between the event the company unidentified Human Papillomavirus (HPV) vaccine was not reported. Upon internal review, the event of seizure was determined to be medically significant. Additional information is not expected.
More
|
||||||||
| 2843259 | 05/30/2025 |
HBHEPB |
MERCK & CO. INC. |
W032685 |
Expired product administered, No adverse event
Expired product administered, No adverse event
|
No additional AE; HCP calling to report a patient was administered PEDVAXHIB today 5/28/2025 after t...
No additional AE; HCP calling to report a patient was administered PEDVAXHIB today 5/28/2025 after the expiration date of 5/8/2025.; This spontaneous report was received from a health care professional referring to a patient. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On 28-MAY-2025, the patient was vaccinated with an expired dose of Haemophilus B conjugate vaccine (Meningococcal protein conjugate) suspension for injection (PEDVAXHIB), for prophylaxis (dose, route of administration, vaccination scheme frequency, and anatomical location were not provided; valid lot number W032685, with expiration date on 08-MAY-2025) (Expired product administered). There was not adverse event reported.
More
|
|||||||||
| 2843260 | F | 05/30/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Myalgia
Myalgia
|
muscle pain in the arm; This non-serious case was reported by a consumer via interactive digital med...
muscle pain in the arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. In APR-2025, the patient received Shingles vaccine. In APR-2025, an unknown time after receiving Shingles vaccine, the patient experienced muscle pain (Verbatim: muscle pain in the arm). The outcome of the muscle pain was not reported. It was unknown if the reporter considered the muscle pain to be related to Shingles vaccine. It was unknown if the company considered the muscle pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 23-MAY-2025 This case was reported by a patient via interactive digital media. The reporter's mother had muscle pain in the arm for a month and a half since the vaccine was given. The muscle pain since vaccine administration one month ago.
More
|
||||||||
| 2843261 | PA | 05/30/2025 |
TDAP |
SANOFI PASTEUR |
U8339BA |
No adverse event, Product storage error
No adverse event, Product storage error
|
Temperature excursion occurred with max/low temp. reached 63.0 F for 96 hours with no reported adver...
Temperature excursion occurred with max/low temp. reached 63.0 F for 96 hours with no reported adverse event; Initial information received on 27-May-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves temperature excursion of Diphtheria-2/Tetanus/5 AC pertussis vaccine [Adacel] occurred with max/low temp. reached 63.0 f for 96 hours with no reported adverse event. On an unknown date, the caller reported that an unknown dose of suspect Diphtheria-2/Tetanus/5 AC pertussis vaccine Suspension for injection (lot U8339BA and expiry date-30-Nov-2026) (strength-unknown) via unknown route in unknown administration site for Immunization with max/low temp. reached 63.0 f for 96 hours with no reported adverse event (product storage error). Reportedly- extended stability data does not cover the excursion, human error was involved (door was left open), The product was not administered Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
More
|
||||||||
| 2843262 | KY | 05/30/2025 |
DTAPIPVHIB |
SANOFI PASTEUR |
UK225AB |
No adverse event, Product preparation issue
No adverse event, Product preparation issue
|
only the liquid portion of pentacel was given to a patient with no reported adverse event; Initial i...
only the liquid portion of pentacel was given to a patient with no reported adverse event; Initial information received on 28-May-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient with unknown age and gender who was administered with only the liquid portion of Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine, Powder and suspension for suspension for injection (lot UK225AB, expiry date 31-Jul-2026; strength standard and frequency once) via unknown route in unknown administration site for Immunization and only the liquid portion of pentacel was given to a patient with no reported adverse event (single component of a two-component product administered) (latency same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
More
|
||||||||
| 2843269 | 6 | F | CO | 05/30/2025 |
MMR |
MERCK & CO. INC. |
|
Confusional state, Crying, Hypotonia, Staring, Unresponsive to stimuli
Confusional state, Crying, Hypotonia, Staring, Unresponsive to stimuli
|
Possible seizure, and started blankly into space for about 15 to 20 seconds, was completely limp and...
Possible seizure, and started blankly into space for about 15 to 20 seconds, was completely limp and unresponsive. Then was sobbing and confused after.
More
|
||||||
| 2843276 | DC | 05/30/2025 |
MMRV VARCEL |
MERCK & CO. INC. MERCK & CO. INC. |
|
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
No additional AEs; patient supposed to only receive VARIVAX but also received PROQUAD along with VAR...
No additional AEs; patient supposed to only receive VARIVAX but also received PROQUAD along with VARIAVX; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 27-MAY-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) for prophylaxis (strength, dose, route, lot #, and expiration date of both vaccines were not reported). The vaccines were reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported). The patient was supposed to only receive Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) but also received Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) along with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (Overdose). No additional adverse events were reported. Lot# is being requested and will be submitted if received.
More
|
||||||||
| 2843277 | PA | 05/30/2025 |
VARCEL |
MERCK & CO. INC. |
Y020586 |
No adverse event, Product storage error
No adverse event, Product storage error
|
No additional AE; that improperly stored VARIVAX was administered; This spontaneous report was recei...
No additional AE; that improperly stored VARIVAX was administered; This spontaneous report was received from a Physician and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 28-May-2025, the patient was vaccinated with improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection (lot #Y020586, expiration date: 17-Dec-2026) 0.5 mL (0.5 mL) for prophylaxis (Improper storage of product in use). Temperature was 40F, Time frame was 2 hours 0 minutes 0 seconds. No previous temperature excursion. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot# and expiration date not reported). No additional AE.
More
|
||||||||
| 2843278 | 05/30/2025 |
VARZOS VARZOS |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
UNK UNK |
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
|
Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactiv...
Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On 23-MAY-2025, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was not reported and the outcome of the shingles was not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK receipt date: 23-MAY-2025 This case was reported by a patient via interactive digital media. The patient got two vaccines and was diagnosed with shingles on the day of reporting. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingles vaccine (dose 1 ) and Shingles vaccine (dose 2).
More
|